Search
for
Sort by
Research 271–300 of 1000+
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Physiological and biological skin changes in pregnancy
- Clinical efficacy of silk sericin dressing with collagen for split-thickness skin graft donor site treatment
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Signal Detection for Adverse Events of Finasteride Using Korea Adverse Event Reporting System (KAERS) Database
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Cutaneous adverse effects of chemotherapy in cancer patients: A clinico epidemiological study
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Skin Biopsy - Diagnosis and Treatment
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers